Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,132

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for

Hepatocellular Carcinoma (HCC)

Location: Houston TX, Birmingham AL, St Louis MO, Omaha NE,

Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase 1, Phase 2, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for

Endometrial Cancer, Gastric Cancer,

Location: Houston TX, Nashville TN, Albuquerque NM, Cincinnati OH,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase 2, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for

Non-small Cell Lung Cancer

Location: Houston TX, Webster TX, Woodway TX, St Louis MO,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase 3, Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for

B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),

Location: Houston TX, Austin TX, San Antonio TX, Nashville TN,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase 2, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for

Non-Small Cell Lung Cancer

Location: Houston TX, Kingwood TX, Fort Worth TX, Hattiesburg MS,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Systemic and Central Inflammation in AD

for

Alzheimer Disease

Location: Houston TX

Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 50 - 70+

Code: NCT06384378

Phase 2, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for

Chronic Kidney Disease and Hypertension

Location: Houston TX, Humble TX, Pasadena TX, Austin TX,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for

Endometrial Cancer

Location: Houston TX, Austin TX, San Antonio TX, Shreveport LA,

Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Non-invasive VNS in Stroke Recovery

for

Stroke

Location: Houston TX

Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06761404

Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

for

Advanced Solid Malignancies

Location: Houston TX, San Antonio TX, Chicago IL, Los Angeles CA,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05417594

Phase 1, Phase 2, Recruiting

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

for

Corneal Ectasia

Location: Houston TX, Ladson SC, Westerville OH, Bloomington MN,

Sponsor: Glaukos Corporation

Sex: All

Age: 18+

Code: NCT03319082

Recruiting

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

for

Ischemic Heart Disease

Location: Houston TX, Louisville KY, Miami FL

Sponsor: Roberto Bolli

Sex: All

Age: 21 - 70+

Code: NCT06145035

Phase 2, Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

for

Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP),

Location: Houston TX, Austin TX, Chapel Hill NC, Baltimore MD,

Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT06371417

Phase 1, Recruiting

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

for

Dermatomyositis, Polymyositis

Location: Houston TX, Glendale AZ

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06698796

Phase 3, Recruiting

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

for

Myositis

Location: Houston TX, Katy TX, Frisco TX, Harlingen TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05895786

Phase 3, Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

for

Psoriatic Arthritis

Location: Bellaire TX, Houston TX, Baytown TX, Lake Charles LA,

Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671483

Phase 3, Recruiting

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

for

Mild Cognitive Impairment, Alzheimer's Disease,

Location: Houston TX, Beaumont TX, Tampa FL, Sarasota FL,

Sponsor: GAP Innovations, PBC

Sex: All

Age: 60 - 70+

Code: NCT06584357

Recruiting

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

for

Bipolar I Disorder, Mania

Location: Houston TX, Austin TX, Little Rock AR, Gaithersburg MD,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07288320

Phase 2, Recruiting

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for

Alzheimers Disease

Location: Houston TX, Katy TX, Beaumont TX, Dallas TX,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for

Schizophrenia

Location: Houston TX, Austin TX, DeSoto TX, Flowood MS, Bryant AR,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase 3, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Interested in new trials?

Systemic and Central Inflammation in AD

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Non-invasive VNS in Stroke Recovery

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia